Sanofi logo
Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
39.77
+0.65 (1.66%)
At close: Oct 14, 2026, 4:00 PM EDT
40.51
+0.74 (1.86%)
Pre-market: Oct 15, 2026, 4:15 AM EDT

Sanofi Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Sanofi stock has a consensus rating of "Buy" and an average price target of $53.61. The average 1-year stock price forecast is 34.80% higher than the current stock price, while the lowest is $44 (+10.64%) and the highest is $63 (+58.41%).

Price Target: $53.61 (+34.80%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$44$53.61$54.5$63
Change+10.64%+34.80%+37.04%+58.41%
* Price targets were last updated on Aug 31, 2026.

Analyst Ratings

The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy455455
Buy100100
Hold555556
Sell000000
Strong Sell000000
Total101010101011

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Hold
Maintains
$57
HoldMaintains$57+43.32%Aug 31, 2026
Unknown Analyst
Berenberg Bank
No rating
Berenberg Bank
Buy
Maintains
$62
BuyMaintains$62+55.90%Aug 24, 2026
Guggenheim
Guggenheim
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 10, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$52 → $49
HoldMaintains$52 → $49+23.21%Jul 8, 2026
Exane BNP Paribas
Exane BNP Paribas
Hold
Downgrades
$50
HoldDowngrades$50+25.72%Apr 20, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
47.37B
from 46.72B
Increased by 1.41%
Revenue Next Year
50.47B
from 47.37B
Increased by 6.55%
EPS This Year
8.62
from 7.83
Increased by 10.12%
EPS Next Year
9.04
from 8.62
Increased by 4.90%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
39.18B40.30B41.11B44.29B46.72B47.37B
Revenue Growth
4.83%2.88%2.00%7.73%5.49%1.41%
Gross Profit
26.92B28.44B28.49B31.09B33.79B35.98B
Gross Margin
68.73%70.55%69.30%70.21%72.34%75.96%
Operating Income
8.57B10.38B8.12B8.87B9.65B13.17B
Net Income
6.22B8.37B5.40B5.56B7.81B7.30B
EPS
----7.838.62
EPS Growth
----9.97%10.12%
Forward PE
-----8.23
Dividend / Share
3.333.563.763.924.124.26
Dividend Growth
4.06%6.91%5.62%4.26%5.10%3.30%
Free Cash Flow
----8.09B8.23B
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High48.4B
Avg47.4B
Low43.3B

Revenue Growth

Revenue Growth202620272028
High
3.7%
Avg
1.4%
Low
-7.2%

EPS Forecast

EPS202620272028
High8.93
Avg8.62
Low8.12

EPS Growth

EPS Growth202620272028
High
14.0%
Avg
10.1%
Low
3.7%